Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Fenoglio

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Blood Purification|August 31, 2006
Cholesterol crystal embolism syndrome in dialysis patients: an emerging clinical diagnosis?Giorgina Barbara Piccoli, Roberta Fenoglio, Loredana Colla, et al.
Journal of Autoimmunity|January 1, 2026
Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case studyDario Roccatello, Alice Barinotti, Massimo Radin, et al.
Scientific Reports|September 1, 2022
Recognizing the new disorder "idiopathic hypocryoglobulinaemia" in patients with previously unidentified clinical conditionsDario Roccatello, Savino Sciascia, Carla Naretto, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 22, 2006
The long-term dialysis patient with purple-blue toesGiorgina Barbara Piccoli, Emanuela Maddalena, Roberta Fenoglio, et al.
Kidney & Blood Pressure Research|December 16, 2020
The Challenging Management of Cancer: An Immunonephrologist's PerspectiveRoberta Fenoglio, Dario Roccatello, Emanuele De Simone, et al.
Clinical and Experimental Rheumatology|May 23, 2020
Rituximab in severe immunoglobulin-A vasculitis (Henoch-Schönlein) with aggressive nephritisRoberta Fenoglio, Savino Sciascia, Carla Naretto, et al.
Thrombosis Research|November 26, 2025
Thrombocytopenia in antiphospholipid syndrome: predictors, prognostic implications, and thrombotic risk in a large cohort studyDavid Galarza, Massimo Radin, Irene Cecchi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 25, 2025
Fibrillary glomerulonephritis: Lessons from anti-CD20 therapy and repeat biopsyRoberta Fenoglio, Savino Sciascia, Emanuele De Simone, et al.
Clinical and Experimental Rheumatology|October 28, 2022
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocolSavino Sciascia, Massimo Radin, Irene Cecchi, et al.
Kidney International Reports|April 29, 2021
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance TherapyDario Roccatello, Savino Sciascia, Carla Naretto, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Blood Purification|August 31, 2006
Cholesterol crystal embolism syndrome in dialysis patients: an emerging clinical diagnosis?Giorgina Barbara Piccoli, Roberta Fenoglio, Loredana Colla, et al.
Journal of Autoimmunity|January 1, 2026
Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case studyDario Roccatello, Alice Barinotti, Massimo Radin, et al.
Scientific Reports|September 1, 2022
Recognizing the new disorder "idiopathic hypocryoglobulinaemia" in patients with previously unidentified clinical conditionsDario Roccatello, Savino Sciascia, Carla Naretto, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 22, 2006
The long-term dialysis patient with purple-blue toesGiorgina Barbara Piccoli, Emanuela Maddalena, Roberta Fenoglio, et al.
Kidney & Blood Pressure Research|December 16, 2020
The Challenging Management of Cancer: An Immunonephrologist's PerspectiveRoberta Fenoglio, Dario Roccatello, Emanuele De Simone, et al.
Clinical and Experimental Rheumatology|May 23, 2020
Rituximab in severe immunoglobulin-A vasculitis (Henoch-Schönlein) with aggressive nephritisRoberta Fenoglio, Savino Sciascia, Carla Naretto, et al.
Thrombosis Research|November 26, 2025
Thrombocytopenia in antiphospholipid syndrome: predictors, prognostic implications, and thrombotic risk in a large cohort studyDavid Galarza, Massimo Radin, Irene Cecchi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 25, 2025
Fibrillary glomerulonephritis: Lessons from anti-CD20 therapy and repeat biopsyRoberta Fenoglio, Savino Sciascia, Emanuele De Simone, et al.
Clinical and Experimental Rheumatology|October 28, 2022
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocolSavino Sciascia, Massimo Radin, Irene Cecchi, et al.
Kidney International Reports|April 29, 2021
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance TherapyDario Roccatello, Savino Sciascia, Carla Naretto, et al.
Pageof 11